Fig. 3.
Fig. 3. Viable (7-AAD−) Lin−FGFR+ cells coexpress both primitive hematopoietic (AC133) and endothelial-specific (VE-cadherin) cell surface markers. / CD34+-enriched cells were isolated from lineage-depleted mobilized peripheral blood and gated to exclude debris with low FSC and cells with high SSC (R1) and nonviable (7-AAD+) cells (R2). (A) R3 defines viable Lin−FGFR+cells. Most of the viable Lin−FGFR+ cells are shown to have low SSC. (B) Boolean gating is used to show coexpression of both AC133 and VE-cadherin by viable Lin−FGFR+ cells. These plots are representative of 2 separate experiments.

Viable (7-AAD) LinFGFR+ cells coexpress both primitive hematopoietic (AC133) and endothelial-specific (VE-cadherin) cell surface markers.

CD34+-enriched cells were isolated from lineage-depleted mobilized peripheral blood and gated to exclude debris with low FSC and cells with high SSC (R1) and nonviable (7-AAD+) cells (R2). (A) R3 defines viable LinFGFR+cells. Most of the viable LinFGFR+ cells are shown to have low SSC. (B) Boolean gating is used to show coexpression of both AC133 and VE-cadherin by viable LinFGFR+ cells. These plots are representative of 2 separate experiments.

Close Modal

or Create an Account

Close Modal
Close Modal